Global /India /Healthcare /Biotechnology /526139
chevron_leftBack
Transgene Biotek Ltd. logo

Transgene Biotek Ltd.

526139
BSE: 526139 Delayed
2.84INR -1.4%
0.0298 USD
As of 6 June 2026, Transgene Biotek Ltd. has a market cap of $2.25M USD, ranking #46922 globally and #4492 in India. It ranks #4153 in the Healthcare sector, and #817 in the Biotechnology industry.
Global Rank
46922
Country Rank
4492
Sector Rank
4153
Industry Rank
817
Key Stats
Market Cap
$2.25MUSD
215.19M INR
Enterprise Value
$3.98MUSD
379.63M INR
Revenue (TTM)
$24.35KUSD
2.33M INR
EBITDA (TTM)
-$92.65KUSD
-8.84M INR
Net Income (TTM)
-$199.37KUSD
-19.09M INR
PS Ratio
92.3
PB Ratio
2.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Koteswara Kanuru open_in_new
Founded
1990
Website
transgenebiotek.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.4% -3.7% 26% 31% -31% -25%

News

Loading...

Markets

Exchange Ticker Price
Bombay Stock Exchange
MIC: XBOM
PRIMARY
526139 (TRABI)
Transgene Biotek Ltd
ISIN: INE773D01018
Shares Out.:
65.77M1
TV:
SA:
YF:
GF:
BA:
MS:
2.84 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Transgene Biotek Ltd.

Transgene Biotek Limited, a biotechnology company, provides research and development services for bulk drugs in India. It offers a portfolio of oncology drugs, oral drug delivery, and biogenerics. The company provides TrabiDHA for use in health food, baby food/formula, health supplement, and chicken and animal feed markets; Tacrolimus, a drug that suppresses the immune system and is used to prevent rejection of transplanted organs; and Orlistat (tetrahydrolipstatin), a lipase inhibitor that blocks about one-third of intestinal fat absorption. The company was incorporated in 1990 and is based in Sangareddy, India.

Similar Companies

Industry: Biotechnology (India)
Name
Market Cap diff.
PE
$4.55B
435.39B INR
202K%
90.4
RUBICON
$1.68B
160.71B INR
75K%
74.8
$869.35M
83.24B INR
39K%
26.2
TITANBIO
$190.84M
18.27B INR
8K%
-
FERMENTA
$96.13M
9.2B INR
4K%
10.6
$79.49M
7.61B INR
3K%
17.1
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
8M%
23.9
GILD
$159.92B
7M%
19.0
ARGX
$48.08B
41.39B EUR
2M%
39.9
$44.48B
68.19T KRW
2M%
35.5
CSL
$43.01B
60.27B AUD
2M%
29.3
LONN
$42.72B
33.71B CHF
2M%
37.2
chevron_leftBack